AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group
Year: 2026
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, Matthew Kutny, Betsy Hirsch, Gordana Raca, Kasey Leger, Jennifer Wilkes, Reena Pabari, Aman Wadhwa, Zachary Graff, Samir Kahwash, Karen Chisholm, Joseph Chewning, John Horan, Richard Aplenc, Andrew Place, Sarah K. Tasian, Katherine Tarlock, Sarah Menig, Olga Militano, Bonnie Ky, Chad Hudson, Michael R. Loken, Andrew Menssen, Lisa Eidenschink Brodersen, Soheil Meshinchi, Edward Anders Kolb, Todd M. Cooper
Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, University of Southern California, Children's Oncology Group, University of Alabama at Birmingham, University of Minnesota, Children's Hospital of Los Angeles, Seattle Children's Hospital, University of Toronto, Hospital for Sick Children, Medical College of Wisconsin, Nationwide Children's Hospital, The Ohio State University, University of Washington, University of Rochester Medicine, Children's Hospital of Philadelphia, Abramson Cancer Center, University of Pennsylvania, Fred Hutch Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7170428815